NCT01483391

Brief Summary

Children or teens with mood swings or depression who have a parent with bipolar disorder are at high risk for developing bipolar disorder themselves. This study will test a family-based therapy aimed at preventing or reducing the early symptoms of bipolar disorder in high-risk children (ages 9-17). In a randomized trial, the investigators will compare two kinds of family-based treatment (one more and one less intensive) on the course of early mood symptoms and social functioning among high-risk children followed for up to 4 years. The investigators will examine the effects of family treatment on measures of neural activation using functional magnetic resonance imaging.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 6, 2011

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 26, 2011

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 1, 2011

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2016

Completed
4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2020

Completed
Last Updated

October 4, 2021

Status Verified

September 1, 2021

Enrollment Period

4.9 years

First QC Date

November 26, 2011

Last Update Submit

September 26, 2021

Conditions

Keywords

Bipolar disorderMajor depressive disorderManiaDepressionCyclothymic Disorder

Outcome Measures

Primary Outcomes (1)

  • Changes in symptom severity

    Changes in symptoms of at-risk children, as defined by depression and (hypo)mania scores and psychiatric status on the Adolescent Longitudinal Interval Follow-up Evaluation (A-LIFE, the Child Depression Rating Scale, and the Young Mania Rating Scale

    Measured at baseline, every 4 months in year 1, and every 6 months in years 2-4

Secondary Outcomes (3)

  • Delaying onset of a first (hypo)manic or mixed episode

    2-4 years

  • Psychosocial functioning

    Measured at baseline, every 4 months in year 1 and every 6 months in years 2-4

  • Mental health service use

    Measured at baseline, every 4 months in year 1 and every 6 months in years 2-4

Study Arms (2)

Enhanced Care

ACTIVE COMPARATOR

Three sessions of family education and three sessions of individual support over 4 months.

Behavioral: Enhanced Care

Family-Focused Treatment

EXPERIMENTAL

12 therapy sessions involving the at-risk child or adolescent, parents, and available siblings. Therapy will include psychoeducation about mood disorders, communication enhancement training, and problem-solving skills training.

Behavioral: Family-Focused Treatment

Interventions

Enhanced CareBEHAVIORAL

The 3 family sessions involve the youth and all family members. These sessions will help the child and family members with mood charting and developing a mood management plan. Families will rehearse mood regulation strategies for current family, social or academic problems. Clinicians then meet with the child individually every month for the next 3 mos. to provide support, assist with problem-solving, and troubleshoot use of the mood management plan.

Also known as: Psychoeducation, Case Management
Enhanced Care

12 therapy sessions involving the at-risk child or adolescent, parents, and available siblings. Therapy will include psychoeducation about mood disorders, communication enhancement training, and problem-solving skills training. The goal of this intervention is to improve the child's ability to regulate moods and to reduce tension and conflict in the family.

Also known as: Family Therapy, Family Psychoeducation, FFT, Family Intervention, Psychoeducation, Family Treatment
Family-Focused Treatment

Eligibility Criteria

Age9 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • For a child to be eligible:
  • At least one biological parent or stepparent with whom the child or adolescent lives must be willing to participate in family treatment
  • At least one biological parent has a verifiable diagnosis of bipolar disorder I or II
  • The child must have a DSM-IV diagnosis of bipolar disorder not otherwise specified or major depressive disorder (MDD)
  • If the main diagnosis is MDD, the depressive episode must have occurred within the past 2 years
  • The child must have evidence of current significant affective symptoms, as determined by a score greater than 11 on the Young Mania Rating Scale within the last week or a score greater than 29 on the Child Depression Rating Scale-Revised within the last 2 weeks
  • The family must speak English, although English need not be their first language

You may not qualify if:

  • Fully diagnosable bipolar disorder I or II
  • Diagnosis of autism or pervasive developmental disorder
  • Evidence of mental retardation, as defined by an intelligence quotient (IQ) less than 70
  • Presence of comorbid neurologic diseases such as seizure disorder
  • Substance or alcohol abuse or dependence disorders in the 4 months prior to study recruitment
  • Evidence of a life-threatening eating disorder or other medical disorder that requires emergency medical treatment
  • Currently enrolled in regular family therapy
  • Evidence of current sexual or physical abuse or domestic abuse between the adult partners

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

UCLA Child and Adolescent Mood Disorders Program, UCLA School of Medicine

Los Angeles, California, 90024-1759, United States

Location

Stanford University School of Medicine, Lucile Packard Children's Hospital

Stanford, California, 94304, United States

Location

University of Colorado, Boulder

Boulder, Colorado, 80309, United States

Location

Related Publications (6)

  • Miklowitz DJ, Chang KD. Prevention of bipolar disorder in at-risk children: theoretical assumptions and empirical foundations. Dev Psychopathol. 2008 Summer;20(3):881-97. doi: 10.1017/S0954579408000424.

    PMID: 18606036BACKGROUND
  • Miklowitz DJ, Chang KD, Taylor DO, George EL, Singh MK, Schneck CD, Dickinson LM, Howe ME, Garber J. Early psychosocial intervention for youth at risk for bipolar I or II disorder: a one-year treatment development trial. Bipolar Disord. 2011 Feb;13(1):67-75. doi: 10.1111/j.1399-5618.2011.00890.x.

    PMID: 21320254BACKGROUND
  • Miklowitz DJ, Weintraub MJ, Singh MK, Walshaw PD, Merranko JA, Birmaher B, Chang KD, Schneck CD. Mood Instability in Youth at High Risk for Bipolar Disorder. J Am Acad Child Adolesc Psychiatry. 2022 Oct;61(10):1285-1295. doi: 10.1016/j.jaac.2022.03.009. Epub 2022 Mar 17.

  • Singh MK, Nimarko AF, Garrett AS, Gorelik AJ, Roybal DJ, Walshaw PD, Chang KD, Miklowitz DJ. Changes in Intrinsic Brain Connectivity in Family-Focused Therapy Versus Standard Psychoeducation Among Youths at High Risk for Bipolar Disorder. J Am Acad Child Adolesc Psychiatry. 2021 Apr;60(4):458-469. doi: 10.1016/j.jaac.2020.07.892. Epub 2020 Aug 1.

  • Miklowitz DJ, Schneck CD, Walshaw PD, Singh MK, Sullivan AE, Suddath RL, Forgey Borlik M, Sugar CA, Chang KD. Effects of Family-Focused Therapy vs Enhanced Usual Care for Symptomatic Youths at High Risk for Bipolar Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2020 May 1;77(5):455-463. doi: 10.1001/jamapsychiatry.2019.4520.

  • Miklowitz DJ, Portnoff LC, Armstrong CC, Keenan-Miller D, Breen EC, Muscatell KA, Eisenberger NI, Irwin MR. Inflammatory cytokines and nuclear factor-kappa B activation in adolescents with bipolar and major depressive disorders. Psychiatry Res. 2016 Jul 30;241:315-22. doi: 10.1016/j.psychres.2016.04.120. Epub 2016 May 7.

Related Links

MeSH Terms

Conditions

Bipolar DisorderDepressive Disorder, MajorManiaDepressionCyclothymic Disorder

Interventions

Case ManagementFamily Therapy

Condition Hierarchy (Ancestors)

Bipolar and Related DisordersMood DisordersMental DisordersDepressive DisorderNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Patient Care PlanningComprehensive Health CarePatient Care ManagementHealth Services AdministrationPsychotherapy, GroupSocioenvironmental TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • David J Miklowitz, PhD

    UCLA Department of Psychiatry

    PRINCIPAL INVESTIGATOR
  • Kiki D Chang, MD

    Stanford University

    PRINCIPAL INVESTIGATOR
  • Christopher D Schneck, MD

    University of Colorado, Denver

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Psychiatry

Study Record Dates

First Submitted

November 26, 2011

First Posted

December 1, 2011

Study Start

October 6, 2011

Primary Completion

September 15, 2016

Study Completion

September 15, 2020

Last Updated

October 4, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will share

Upon completing the study we will submit a CD-ROM to the NIH Freedom of Information Act Coordinator containing all raw data, variable coding information, and copies of measures. Prior to archiving the data, we will remove all personal identifiers and other protected information. The youth's and parents' consent forms will make clear that the data, minus any identifying information, will be made available to other researchers at the end of the study.

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
1/01/21-1/01/23

Locations